Filing Details

Accession Number:
0001127602-19-020022
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-05-28 16:37:52
Reporting Period:
2019-05-24
Accepted Time:
2019-05-28 16:37:52
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
943819 Resmed Inc RMD Surgical & Medical Instruments & Apparatus (3841) 980152841
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1231182 P John Wareham 761 Mission Creek Drive
Palm Springs CA 92211
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Resmed Common Stock Acquisiton 2019-05-24 11,085 $51.25 24,085 No 4 M Direct
Resmed Common Stock Disposition 2019-05-24 11,085 $113.44 13,000 No 4 S Direct
Resmed Common Stock Acquisiton 2019-05-24 9,628 $51.25 22,628 No 4 M Direct
Resmed Common Stock Disposition 2019-05-24 9,628 $114.00 13,000 No 4 S Direct
Resmed Common Stock Acquisiton 2019-05-24 23,629 $52.02 36,629 No 4 M Direct
Resmed Common Stock Disposition 2019-05-24 23,629 $114.00 13,000 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Resmed Common Stock ResMed Common Stock Options Disposition 2019-05-24 11,085 $0.00 11,085 $51.25
Resmed Common Stock ResMed Common Stock Options Disposition 2019-05-24 9,628 $0.00 9,628 $51.25
Resmed Commmon Stock ResMed Common Stock Options Disposition 2019-05-24 23,629 $0.00 23,629 $52.02
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
9,628 2016-11-11 2020-11-13 No 4 M Direct
0 2016-11-11 2020-11-13 No 4 M Direct
0 2015-11-11 2021-11-19 No 4 M Direct
Footnotes
  1. This transaction was executed in multiple trades at prices ranging from $113.44 to $113.45. The price reported above reflects the weighted average sale price.
  2. Represents date options first became exercisable. Options vest on the earlier of (i) the first November 11 following the Grant Date, or (ii) the date of the first (1st) annual meeting of stockholders of the Company following the Grant Date.